Equity Capital Markets

Company · CIK 1514946

AXIM BIOTECHNOLOGIES, INC.

CIK1514946 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inNV
Business addressCA
ListedAXIM (OTC)
First annual or quarterly report2011-11-17

Offerings

4 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-272390
Registered companyEffective
2023-06-022023-06-092
333-266305
Registered companyEffective
2022-07-252022-08-043
333-256162
Registered companyEffective
2021-05-142021-06-223
333-220155
ShelfEffective
2017-08-242019-12-174

Filings

12
FiledFilingRegistrationAccession
2023-06-09EFFECTDeclared effective 333-2723909999999995-23-001716
2023-06-02S-1Registration filed 333-2723900001096906-23-001240
2022-08-04EFFECTDeclared effective 333-2663059999999995-22-002259
2022-08-02S-1/AAmendment 333-2663050001096906-22-001752
2022-07-25S-1Registration filed 333-2663050001096906-22-001690
2021-06-22EFFECTDeclared effective 333-2561629999999995-21-002438
2021-06-09S-1/AAmendment 333-2561620001078782-21-000551
2021-05-14S-1Registration filed 333-2561620001078782-21-000445
2019-12-17424B5Shelf takedown 333-2201550001078782-19-000917
2018-04-18424B5Shelf takedown 333-2201550001078782-18-000450
2017-09-14EFFECTDeclared effective 333-2201559999999995-17-002358
2017-08-24S-3Shelf registered 333-2201550001078782-17-001212

All filings of this company · CSV